This is a prospective study to evaluate the performance and safety of a new medical device used in case of cerebrospinal fluid (CSF) leakage after an elective cranial surgery.
Patients who consented to participate in the trial and fulfilled the preoperative inclusion and exclusion criteria underwent screening prior to surgical treatment. After dural suturing, if patients met the intra operative inclusion and exclusion criteria, they received I-020805. If necessary, autologous grafts were to be used to augment dural closure. I-020805 was delivered from a double syringe applicator that creates a fine layer over the dura. This layer quickly sets within seconds to form a watertight seal.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
PREVENTION
Masking
NONE
Enrollment
41
A thin layer of I-020805 applied up to two times on the sutured dura mater
Charite Universitätsmedizin (01)
Berlin, Germany
Orszagos Idegtudomanyi Intezet (11)
Budapest, Hungary
Debreceni Tudomanyegyetem (12)
Debrecen, Hungary
Szegedi Tudomanyegyetem (10)
Szeged, Hungary
Performance of I-020805 in prevention of CSF leakage
Time frame: Intraoperative on the day of sugery
Incidence of CSF leakage
Time frame: Within 7 days after surgery or prior to discharge
CSF leakage or pseudomeningocele related surgical intervention
Time frame: Within 90 days following surgery
CSF leakage confirmed by clinical evaluation or diagnostic testing
Time frame: Within 90 days following surgery
Surgical infection and unexpected neurological signs
Time frame: Post-operative and within 7 days and 90 following surgery
Wound healing impairment
Time frame: Throughout study up to 90 days following surgery
Incidence of all and treatment emergent adverse events
Time frame: Throughout study up to 90 days following surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.